 Unsolicited non-serious adverse events AEs will be collected from the time of the first study vaccination through approximately 1 month after each study vaccination. New-onset chronic medical conditions and Serious Adverse Events SAEs will be collected from the time of the first study vaccination through approximately 9 months after the third study vaccination final visit. Clinical laboratory evaluations for safety will be performed on venous blood collected approximately 14 days after each vaccination. 